QS Batterymarch Financial Management’s Ionis Pharmaceuticals IONS Stock Holding History

QS Batterymarch Financial Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.54M	Sell	142,740 -12,880	-8%	-$456K	0.15%	211
2014 Q2	$5.36M	Sell	155,620 -32,260	-17%	-$1.02M	0.14%	255
2014 Q1	$8.12M	Sell	187,880 -3,050	-2%	-$148K	0.17%	165
2013 Q4	$7.61M	Sell	190,930 -6,870	-3%	-$245K	0.16%	188
2013 Q3	$7.43M	Hold	197,800	–	–	0.16%	188
2013 Q2	$5.32M	Buy	+197,800	New	+$4.21M	0.1%	298

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Batterymarch Financial Management's IONS Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Ionis Pharmaceuticals (IONS) stake by 8.3% in Q3 2014, selling an estimated $456K and leaving 142,740 shares worth $5.54M. The position accounts for 0.15% of the portfolio, ranked #211.

QS Batterymarch Financial Management first reported a position in IONS in Q2 2013 and has held it in 6 quarters since. The position peaked at $8.12M in Q1 2014. 240 funds tracked by Wall St. Rank hold IONS as of Q3 2014.

QS Batterymarch Financial Management held 142,740 shares of Ionis Pharmaceuticals worth $5.54M as of Q3 2014.
QS Batterymarch Financial Management sold 12,880 Ionis Pharmaceuticals shares in Q3 2014, an estimated $456K.
Ionis Pharmaceuticals made up 0.15% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #211 holding.
QS Batterymarch Financial Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's Ionis Pharmaceuticals position peaked at $8.12M in Q1 2014.
240 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.